06/05/2023 Corporate Governance Regulations of Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company (Bidiphar) – 2023
28/04/2023 Explanation for the Variance of 10% or More in Net Profit After Tax on the Consolidated and Separate Financial Statements for the First Quarter of 2023 Compared to the Same Period in 2022
10/04/2023 List of Candidates for Election to the Board of Directors: Mr. Nguyễn Ngọc Dũng, Mr. Trương Thanh Liêm
31/03/2023 Letter of Resignation from the Position of Chairman of the Board of Directors by Mr. Nguyễn Văn Quá
31/03/2023 Decision of the Board of Directors on the Dismissal of Mr. Nguyễn Văn Quá from the Position of Chairman of the Board of Directors
31/03/2023 Decision of the Board of Directors on the Election of Mr. Nguyễn Tiến Hải as Chairman of the Board of Directors
28/03/2023 Explanation for the Variance of 10% or More in Net Profit After Tax on the Consolidated and Separate Financial Statements for 2022 Compared to the Same Period of the Previous Year
30/01/2023 Explanation for the variance of 10% or more in net profit after tax on the separate financial statements for the fourth quarter of 2022 compared to the same period of the previous year
30/01/2023 Explanation for the variance of 10% or more in net profit after tax on the consolidated financial statements for the fourth quarter of 2022 compared to the same period of the previous year
26/10/2022 Explanation of the difference of 10% or more in NPAT of the 3rd quarter consolidated financial statements of the third quarter of 2022 compared to the same period last year
26/10/2022 Explanation for the variance of 10% or more in net profit after tax on the consolidated financial statements for the third quarter of 2022 compared to the same period of the previous year
